DRKS00013526
Recruiting
N/A
Evaluation of suitable criteria for the therapy of uterine fibroids by MR-guided high-intensity focused ultrasound (MR-HIFU) - HIFU-Myom
Klinikum der Universität München, Campus Großhadern0 sites75 target enrollmentMay 25, 2018
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- D25.0
- Sponsor
- Klinikum der Universität München, Campus Großhadern
- Enrollment
- 75
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age of at least 18 years.
- •2\. Current creatinine
- •3\. Indication for local ablative therapy by means of HIFU
- •4\. Accessibility of the fibroid / fibroids with HIFU
- •5\. Funaki Type I\-II
- •6\. Signed declaration of consent with compliance incl. Follow\-up treatment with compliance including follow\-up treatment
- •7\. Size of fibroid \<12 cm
- •8\. Exclusion of a leiomyosarcoma
- •9\. Signed declaration of consent
Exclusion Criteria
- •1\. Taking Ulipristalacetat (Esmya) over the past 6 months
- •2\. General MRI contraindications (pacemakers, metal parts)
- •3\. contrast agent allergy
- •4\. Significantly reduced general condition
- •5\. Massive obesity (BMI\> 40\)
- •6\. Patients with mental / psychiatric disorders
- •7\. pregnancy
- •8\. intrauterine Device
- •9\. Funaki Type III\-IV
- •10\. Pedunculated serous fibroid
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Examination of the usefulness for the treatment of ulcerative colitis through the change of enterobacterial flora derived by adacolumn treatment.ulcerative colitisJPRN-UMIN000017179Kyoto Prefectural University of Medicine, Department of Molecular Gastroenterology and Hepatology100
Not Yet Recruiting
Phase 2
Clinical management of maantha sanni(Autism spectrum disorder)with maantha sanni thylam(Internal&External)Health Condition 1: null- 1 Poor eye contact 2 Mild aggresive behavior 3 Repetative behavior 4 Lack of communication skillsCTRI/2018/08/015287ATIONAL INSTITUTE OF SIDDHA
Recruiting
Phase 1
Determination of effective therapeutic regimen via Levamisole in controlling the idiopathic nephrotic syndrome relapse among childreIRCT20180519039715N3Kermanshah University of Medical Sciences188
Completed
Phase 3
Maha analuruva chooranam (internal) and Chennagarapattai ennai (external)for the management of Baalavatham(Paresis) in childreHealth Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereCTRI/2021/08/035549ational Institute of Siddha30
Completed
N/A
Evaluation of the treatment standard: Treatment of severe acute lung injury by extracorporeal membrane oxygenatiosevere acute respiratory distress syndromeDRKS00013967niversitätsmedizin Mannheim24